Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate

Gabriella Moroni, Mariele Gatto, Francesca Raffiotta, Valentina Binda, Eleni Frangou, Liz Lightstone, Dimitrios T. Boumpas

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Lupus nephritis (LN) treatment requires an initial intensive period of therapy followed by a long-term maintenance treatment in order to stabilize disease control and eventually reach renal remission. In this section, Authors discuss the feasibility of safely lowering and even suspending maintenance therapy in LN patients having entered remission, highlighting hurdles in predicting the depth and durability of disease quiescence together with the need for minimizing potentially toxic therapies. Even though no firm conclusions can still be drawn, the treating physician has to find the wise balance between disease control and treatment-related drawbacks by following patients closely and recognizing as early as possible the ones who are likely to reach a deep and durable renal remission; there is consensus that is these are the only patients in whom a potential safe complete withdrawal can be foreseen so far.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalAutoimmunity Reviews
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Lupus Nephritis
Immunosuppressive Agents
Therapeutics
Kidney
Poisons
Physicians

Keywords

  • Immunosuppression
  • Lupus nephritis
  • Organ damage
  • Remission

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate. / Moroni, Gabriella; Gatto, Mariele; Raffiotta, Francesca; Binda, Valentina; Frangou, Eleni; Lightstone, Liz; Boumpas, Dimitrios T.

In: Autoimmunity Reviews, Vol. 17, No. 1, 01.01.2018, p. 11-18.

Research output: Contribution to journalReview article

Moroni, G, Gatto, M, Raffiotta, F, Binda, V, Frangou, E, Lightstone, L & Boumpas, DT 2018, 'Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate', Autoimmunity Reviews, vol. 17, no. 1, pp. 11-18. https://doi.org/10.1016/j.autrev.2017.11.003
Moroni, Gabriella ; Gatto, Mariele ; Raffiotta, Francesca ; Binda, Valentina ; Frangou, Eleni ; Lightstone, Liz ; Boumpas, Dimitrios T. / Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate. In: Autoimmunity Reviews. 2018 ; Vol. 17, No. 1. pp. 11-18.
@article{2694044f840d47199cacc9133e6af88a,
title = "Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate",
abstract = "Lupus nephritis (LN) treatment requires an initial intensive period of therapy followed by a long-term maintenance treatment in order to stabilize disease control and eventually reach renal remission. In this section, Authors discuss the feasibility of safely lowering and even suspending maintenance therapy in LN patients having entered remission, highlighting hurdles in predicting the depth and durability of disease quiescence together with the need for minimizing potentially toxic therapies. Even though no firm conclusions can still be drawn, the treating physician has to find the wise balance between disease control and treatment-related drawbacks by following patients closely and recognizing as early as possible the ones who are likely to reach a deep and durable renal remission; there is consensus that is these are the only patients in whom a potential safe complete withdrawal can be foreseen so far.",
keywords = "Immunosuppression, Lupus nephritis, Organ damage, Remission",
author = "Gabriella Moroni and Mariele Gatto and Francesca Raffiotta and Valentina Binda and Eleni Frangou and Liz Lightstone and Boumpas, {Dimitrios T.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.autrev.2017.11.003",
language = "English",
volume = "17",
pages = "11--18",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate

AU - Moroni, Gabriella

AU - Gatto, Mariele

AU - Raffiotta, Francesca

AU - Binda, Valentina

AU - Frangou, Eleni

AU - Lightstone, Liz

AU - Boumpas, Dimitrios T.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Lupus nephritis (LN) treatment requires an initial intensive period of therapy followed by a long-term maintenance treatment in order to stabilize disease control and eventually reach renal remission. In this section, Authors discuss the feasibility of safely lowering and even suspending maintenance therapy in LN patients having entered remission, highlighting hurdles in predicting the depth and durability of disease quiescence together with the need for minimizing potentially toxic therapies. Even though no firm conclusions can still be drawn, the treating physician has to find the wise balance between disease control and treatment-related drawbacks by following patients closely and recognizing as early as possible the ones who are likely to reach a deep and durable renal remission; there is consensus that is these are the only patients in whom a potential safe complete withdrawal can be foreseen so far.

AB - Lupus nephritis (LN) treatment requires an initial intensive period of therapy followed by a long-term maintenance treatment in order to stabilize disease control and eventually reach renal remission. In this section, Authors discuss the feasibility of safely lowering and even suspending maintenance therapy in LN patients having entered remission, highlighting hurdles in predicting the depth and durability of disease quiescence together with the need for minimizing potentially toxic therapies. Even though no firm conclusions can still be drawn, the treating physician has to find the wise balance between disease control and treatment-related drawbacks by following patients closely and recognizing as early as possible the ones who are likely to reach a deep and durable renal remission; there is consensus that is these are the only patients in whom a potential safe complete withdrawal can be foreseen so far.

KW - Immunosuppression

KW - Lupus nephritis

KW - Organ damage

KW - Remission

UR - http://www.scopus.com/inward/record.url?scp=85042309805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042309805&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2017.11.003

DO - 10.1016/j.autrev.2017.11.003

M3 - Review article

C2 - 29108824

AN - SCOPUS:85042309805

VL - 17

SP - 11

EP - 18

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 1

ER -